Want to see ASTH full AI Analyst Report?
ASTH Stock Chart & Stats
$38.19
-$2.12(-5.26%)
At close: 4:00 PM EDT
$38.19
-$2.12(-5.26%)
Day’s Range― - ―
52-Week Range$18.08 - $51.60
Previous Close$38.19
Volume598.74K
Average Volume (3M)694.19K
Market Cap
$1.87B
Enterprise Value$2.66K
Total Cash (Recent Filing)$400.79M
Total Debt (Recent Filing)$979.41M
Price to Earnings (P/E)49.3
Beta1.06
Next Earnings
Nov 05, 2026EPS Estimate
0.44Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.83
Shares Outstanding49,604,366
10 Day Avg. Volume571,928
30 Day Avg. Volume694,191
Financial Highlights & Ratios
PEG Ratio-1.09
Price to Book (P/B)1.56
Price to Sales (P/S)0.38
P/FCF Ratio11.65
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$52.83Price Target Upside38.34% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8
EPS Forecast (FY)1.27
Revenue Forecast (FY)$4.00B
Bulls Say, Bears Say
Bulls Say
Free Cash Flow StrengthSustained FCF well above accounting profits demonstrates real cash-generation capacity. That recurring excess liquidity funds debt paydown, strategic tuck-ins, and reinvestment without relying on equity raises, improving financial resilience over the next several quarters.
Large, Fast Revenue Scale-upRapid multi-year top-line expansion establishes scale advantages across contracting, tech amortization and provider network leverage. Persistent revenue growth supports long‑term margin recovery opportunities and spreads fixed platform costs across a larger base.
Full-risk Membership ScaleA high share of full‑risk contracts and large membership create predictable revenue and align incentives for cost control. Combined with data scale, this strengthens negotiation leverage with payers and sustains value‑based care economics over multiple quarters.
Bears Say
Severe Margin CompressionMaterial margin deterioration reduces earnings sensitivity to revenue growth and limits cash retained from operations. If structural cost or pricing pressures persist, margin recovery will be slow, constraining reinvestment and returns even with continued top‑line expansion.
Medicaid Membership Attrition RiskSignificant Medicaid churn, especially in California, creates structural revenue and membership volatility. Persistent state program shifts or enrollment declines can erode scale economics, raise unit costs, and force contract repricing or strategic rebalancing over the medium term.
Thin Cash‑flow Relative To DebtEven with recent deleveraging, limited operating cash flow versus debt leaves the firm exposed to shocks. A downturn or slower FCF conversion would tighten liquidity, constrain strategic options and increase refinancing or covenant risk across the next several quarters.
ASTH FAQ
What was Astrana Health Inc.’s price range in the past 12 months?
Astrana Health Inc. lowest stock price was $18.08 and its highest was $51.60 in the past 12 months.
What is Astrana Health Inc.’s market cap?
Astrana Health Inc.’s market cap is $1.87B.
When is Astrana Health Inc.’s upcoming earnings report date?
Astrana Health Inc.’s upcoming earnings report date is Nov 05, 2026 which is in 81 days.
How were Astrana Health Inc.’s earnings last quarter?
Astrana Health Inc. released its earnings results on Aug 06, 2026. The company reported $0.4 earnings per share for the quarter, beating the consensus estimate of $0.336 by $0.064.
Is Astrana Health Inc. overvalued?
According to Wall Street analysts Astrana Health Inc.’s price is currently Undervalued.
Does Astrana Health Inc. pay dividends?
Astrana Health Inc. does not currently pay dividends.
What is Astrana Health Inc.’s EPS estimate?
Astrana Health Inc.’s EPS estimate is 0.44.
How many shares outstanding does Astrana Health Inc. have?
Astrana Health Inc. has 49,604,366 shares outstanding.
What happened to Astrana Health Inc.’s price movement after its last earnings report?
Astrana Health Inc. reported an EPS of $0.4 in its last earnings report, beating expectations of $0.336. Following the earnings report the stock price went up 4.776%.
Which hedge fund is a major shareholder of Astrana Health Inc.?
Currently, no hedge funds are holding shares in ASTH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Astrana Health Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$52.83 (38.34% Upside)
$52.83 (38.34% Upside)
Blogger Sentiment
Bullish
ASTH Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 224.5K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Positive
Last 7 Days ▼ 1.5%
Last 30 Days ▲ 4.7%
Last 30 Days ▲ 4.7%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
64.11%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
58.22%
Trailing 12-Months
Company Description
Astrana Health Inc.
Astrana Health, Inc., which rebranded from Apollo Medical Holdings, Inc. in February 2024, is a healthcare management firm based in Alhambra, California, founded in 1985. This company delivers medical services throughout the United States, operating with a physician-centered approach powered by advanced technology. Its operations are structured across three distinct divisions: Care Partners, Care Delivery, and Care Enablement. Astrana Health utilizes its exclusive platform for population health management and healthcare delivery to implement an integrated, value-based care model. This strategic approach empowers the healthcare providers within its network to offer high-quality care to their patients. The organization provides extensive care coordination services to a broad spectrum of stakeholders, including patients, their families, primary care physicians, specialists, acute care hospitals, other inpatient facilities, physician groups, and health plans. Its robust physician network encompasses primary care doctors, specialized practitioners, advanced practice providers (extenders), and hospital-based physicians. Astrana Health serves a diverse patient base, primarily those with insurance coverage—such as private plans, Medicare, Medicaid, and HMOs—but also extends care to uninsured individuals.
ASTH Company Deck
ASTH Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed strong operational and financial momentum: substantial year-over-year top-line and profitability growth, improved operating leverage from AI-driven automation, meaningful cash generation and accelerated de-leveraging, successful integration of Prospect with expected synergies, and raised EBITDA guidance. Offsetting these positives are ongoing Medicaid membership attrition and program-specific headwinds in California, slightly elevated commercial cost trends, a minor one-time $15 million ACO REACH revenue reduction, and some uncertainty around exchange and Medicaid dynamics. On balance, the positive execution, scale gains, and trajectory of the AI-native operating system materially outweigh the near-term challenges and conservatively guided risks.View all ASTH earnings summariesASTH Stock 12 Month Forecast
All Analysts
Top Analysts
Average Price Target
$52.83
▲(38.34% Upside)
Technical Analysis
1 Day
3 Days
1 Week
1 Month
Healthcare Services
―
Pediatrix Medical Group
―
―
US Physical Therapy
―
Aveanna Healthcare Holdings
―
Ownership Overview
36.13% Insiders
16.57% Mutual Funds
9.70% Other Institutional Investors
12.97% Public Companies and
Individual Investors







